Herwig-Carl MC, Loeffler KU, Schulze I, Holz FG, Geerling G. [Bottlenecks in the availability of ophthalmological medications : Initiative of the Working Group on Ethics in Ophthalmology of the DOG and the University Eye Clinic Bonn].
Ophthalmologie 2023;
120:178-183. [PMID:
35925354 DOI:
10.1007/s00347-022-01695-3]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 06/27/2022] [Indexed: 02/07/2023]
Abstract
BACKGROUND
Bottlenecks in drug supply in the field of ophthalmological are continuously increasing in Germany. So far, these have hardly been communicated and discussed. We see the transparent presentation of the problem as a first step in compiling concepts to counteract this development.
AIM OF THE WORK
Presentation of the supply shortages in ophthalmological drugs.
MATERIAL AND METHODS
A listing and discussion of the shortages in drug supply to the best of our knowledge are presented.
RESULTS
We distinguish between the problems in (1) supply shortages, (2) discontinuation of production, (3) lack of availability in Germany and (4) manufacture of drugs in specialized pharmacies often lacking approval for the ophthalmological indications.
DISCUSSION
The reasons for drug supply shortages in ophthalmology are complex and therefore no easy solutions can be expected; however, industrial and regulatory authorities at the national and European levels are called upon to analyze the underlying problems and to find appropriate solutions.
Collapse